← Stock Trading Canary · All insider profiles
INSIDER PROFILE · SE
Per-Göran Gillberg
Styrelseledamot
Profile key: se|per-göran gillberg
Purchase history
- Companies traded
- 3
- Purchases · 12M
- 3
- Purchases · 24M
- 4
- Average purchase
- SEK 183,680
- Gross purchase value
- SEK 734,721
- Last purchase
- 2026-06-22
- Completed 20D events
- 4.0
- Outcome status
- INSUFFICIENT_SAMPLE
Latest company: Dicot
Companies: Alzinova AB | Dicot | Dicot Pharma AB
Post-purchase outcomes
Benchmark-relative outcomes are available against OMX Stockholm 30.
- Excess return = stock return − OMX Stockholm 30 return over the same period.
- Hit rate = positive excess-return events ÷ completed events.
- Price coverage = valid point-in-time prices ÷ events mature enough for that period.
- Returns start on the first shared trading session on or after publication.
| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 4Small sample | 100.0% (4/4) | 25.0% (1/4) | -8.4% | -8.4% | -17.3% |
| 20D | 4Small sample | 100.0% (4/4) | 0.0% (0/4) | -19.7% | -19.9% | -24.3% |
| 60D | 4Small sample | 100.0% (4/4) | 25.0% (1/4) | -20.8% | -23.1% | -59.3% |
| 120D | 2Small sample | 100.0% (2/2) | 0.0% (0/2) | -48.4% | -48.4% | -52.2% |
Research patterns
- First purchase in 12M
- 1/3
- Large purchase ≥ €100k
- 0/4
- Cluster buying · 15D
- 1/4
- Buying the dip · ≥20% below prior 52W high
- 4/4
- Routine / opportunistic
- Not classifiable
Counts are profile-wide, point-in-time research labels. They never affect the insider score or ranking.
Every completed outcome is shown; n<5 is descriptive small-sample evidence and is not scored. Disclosure-level observations published on the same date may share a return path and may not be statistically independent. These results never affect the insider score or ranking.